Bio-Rad and Bruker will jointly develop and market products based on Bio-Rad's SELDI technology and MALDI-TOF/TOF mass spectrometers, as a result of a contract signed by the two companies.
These SELDI- (surface-enhanced laser desorption/ionization) and MALDI-TOF/TOF- (matrix-assisted laser desorption/ionization time-of-flight) based products will be used in applications of high-throughput protein profiling and identification.
They will provide new solutions for biomarker discovery, in particular for the detection and high-confidence identification of intact peptides and proteins under 30 kilodaltons.